Venlafaxine Hydrochloride (Page 14 of 14)

Package/Label Display Panel

Venlafaxine Hydrochloride Extended-Release Capsules, USP

37.5 mg*

100 Capsules

carton label
(click image for full-size original)

Package/Label Display Panel

Venlafaxine Hydrochloride Extended-Release Capsules, USP

75 mg*

100 Capsules

carton label
(click image for full-size original)

Package/Label Display Panel

Venlafaxine Hydrochloride Extended-Release Capsules, USP

150 mg*

100 Capsules

carton label
(click image for full-size original)
VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride capsule, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0904-7075(NDC:68382-034)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) VENLAFAXINE 37.5 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CETOSTEARYL ALCOHOL
GELATIN, UNSPECIFIED
HYPROMELLOSE, UNSPECIFIED
MICROCRYSTALLINE CELLULOSE
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)
SODIUM LAURYL SULFATE
TALC
TITANIUM DIOXIDE
FERROSOFERRIC OXIDE
Product Characteristics
Color GRAY (GRAY) , WHITE (WHITE) Score no score
Shape CAPSULE (CAPSULE) Size 16mm
Flavor Imprint Code ZA;35;37;5;mg
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0904-7075-61 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK
1 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK This package is contained within the CARTON (0904-7075-61)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090174 06/01/2011
VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride capsule, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0904-7077(NDC:68382-035)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) VENLAFAXINE 75 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CETOSTEARYL ALCOHOL
GELATIN, UNSPECIFIED
HYPROMELLOSE, UNSPECIFIED
MICROCRYSTALLINE CELLULOSE
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)
SODIUM LAURYL SULFATE
TALC
TITANIUM DIOXIDE
FERRIC OXIDE RED
FERROSOFERRIC OXIDE
Product Characteristics
Color ORANGE (PEACH) , WHITE (WHITE) Score no score
Shape CAPSULE (CAPSULE) Size 20mm
Flavor Imprint Code ZA;36;75;mg
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0904-7077-61 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK
1 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK This package is contained within the CARTON (0904-7077-61)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090174 06/01/2011
VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride capsule, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0904-7076(NDC:68382-036)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
VENLAFAXINE HYDROCHLORIDE (VENLAFAXINE) VENLAFAXINE 150 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
CETOSTEARYL ALCOHOL
GELATIN, UNSPECIFIED
HYPROMELLOSE, UNSPECIFIED
MICROCRYSTALLINE CELLULOSE
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)
SODIUM LAURYL SULFATE
TALC
TITANIUM DIOXIDE
FERRIC OXIDE RED
FERROSOFERRIC OXIDE
Product Characteristics
Color ORANGE (DARK ORANGE) , WHITE (WHITE) Score no score
Shape CAPSULE (CAPSULE) Size 21mm
Flavor Imprint Code ZA;37;150;mg
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0904-7076-61 100 BLISTER PACK in 1 CARTON contains a BLISTER PACK
1 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK This package is contained within the CARTON (0904-7076-61)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA090174 06/01/2011
Labeler — Major Pharmaceuticals (191427277)

Revised: 10/2021 Major Pharmaceuticals

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

https://medlibrary.org/lib/rx/meds/venlafaxine-hydrochloride-47/page/14/

Clinical Trials

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.